These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1691375

  • 1. Effects of a novel renin inhibitor in patients with essential hypertension.
    Bursztyn M, Gavras I, Tifft CP, Luther R, Boger R, Gavras H.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):493-500. PubMed ID: 1691375
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A, Covi G, Capuzzo MG, Lechi C, Minuz P, Delva P, Scuro LA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [Abstract] [Full Text] [Related]

  • 6. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B, Gavras I, Brunner HR, Cook CA, Charocopos F, Gavras HP.
    Am Heart J; 1982 Mar; 103(3):384-90. PubMed ID: 6278905
    [Abstract] [Full Text] [Related]

  • 7. Renin inhibition with A-64662: effect on blood pressure and hormonal response in man.
    Bursztyn M, Gavras I, Tifft CP, Bauer JH, Melby JC, Gavras H.
    J Hypertens Suppl; 1989 Dec; 7(6):S306-7. PubMed ID: 2698944
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [Abstract] [Full Text] [Related]

  • 13. Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients.
    Jeunemaître X, Ménard J, Nussberger J, Guyene TT, Brunner HR, Corvol P.
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):819-27. PubMed ID: 2686709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].
    Stumpe KO, Vetter H, Hessenbruch V, Düsing R, Kolloch R, Krück F.
    Klin Wochenschr; 1975 Oct 01; 53(19):907-11. PubMed ID: 241876
    [Abstract] [Full Text] [Related]

  • 19. Aliskiren monotherapy results in the greatest and the least blood pressure lowering in patients with high- and low-baseline PRA levels, respectively.
    Stanton AV, Dicker P, O'Brien ET.
    Am J Hypertens; 2009 Sep 01; 22(9):954-7. PubMed ID: 19556972
    [Abstract] [Full Text] [Related]

  • 20. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr 01; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.